Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer

Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1,335 public trials 330 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer trial results

Completed

Osimertinib (AZD9291) in First-line Locally Advanced or Metastatic NSCLC Patients With EGFR and EGFR T790M

NCT02841579

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • MedSIR Investigative Site A Coruña, Spain
  • MedSIR Investigative Site Barcelona, Spain
  • MedSIR Investigative Site Barcelona, Spain
  • MedSIR Investigative Site Bilbao, Spain
View Trial Details
Completed

Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device

NCT06789224

Conditions
Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +74 more
Locations
  • Kliniken der Stadt Köln gGmbH Cologne, North Rhine-Westphalia, Germany
  • Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie Universitätsklinikum Frankfurt Frankfurt, Germany
  • Universitätsmedizin der Johannes Gutenberg-Universität Mainz Klinik für Anästhesiologie Mainz, Germany
  • Universitätsmedizin Mannheim, Klinik für Urologie und Urochirurgie Mannheim, Germany
View Trial Details
Completed

LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer

NCT01828099

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +13 more
Locations
  • Novartis Investigative Site CABA, Buenos Aires, Argentina
  • Novartis Investigative Site CABA, Buenos Aires, Argentina
  • Novartis Investigative Site La Rioja, Argentina
  • Novartis Investigative Site Woolloongabba, Queensland, Australia
View all 167 locations
View Trial Details
Completed

Study of Durvalumab Following Radiation Therapy in Patients With Stage 3 Unresectable NSCLC Ineligible for Chemotherapy

NCT04249362

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Tampa, Florida, United States
  • Research Site Royal Oak, Michigan, United States
  • Research Site Limoges, France
View all 35 locations
View Trial Details
Completed

A First in Human, Dose Escalation Study of JAB-3068 （SHP2 Inhibitor） in Adult Patients With Advanced Solid Tumors

NCT03518554

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +40 more
Locations
  • HealthONE Clinic Services Oncology-Hematology Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

A Study Comparing SB8 and Avastin® in Patients With Advanced Non-squamous Non-small Cell Lung Cancer

NCT02754882

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Brest Regional Oncology Dispensary Brest, Belarus
  • Grodno Regional Clinical Hospital Grodno, Belarus
  • N. N. Alexandrov Republican Scientific and Practical Center of Oncology and Medical Radiology Lesnoy, Belarus
  • Minsk city Clinical Oncological Dispensary Minsk, Belarus
View all 105 locations
View Trial Details

Related conditions